Tobacco smoke contains many alkylating agents that can react with DNA to produce O 4 -ethylthymidine (O 4 -etT) and several other types of promutagenic base modifications. Our aims were (i) to confirm results of a pilot study (Godschalk, R., Nair, J., Schooten, F. J., Risch, A., Drings, P., Kayser, K., Dienemann, H. and Bartsch, H. -etT levels ranged from 0.01 to 3.91 adducts/10 8 thymidines. In the combined group of subjects who smoked until surgery or gave up smoking at most 1 year before it, the mean level of O 4 -etT was 1.7-fold (P 5 0.015) and of bulky DNA adducts 2.2-fold (P < 0.0001) higher than in long-term ex-smokers (LES) and never-smokers (NS) combined. We found no significant correlation between the individual levels of the two DNA adduct types. No dose-response was detected between O 4 -etT formation and smoking dose. In one-third of LES, O 4 -etT levels were above the 2.0-fold mean level of adducts found in NS, indicating its high persistence. Our results confirm the smoking-related formation of O
Introduction
The major risk factor for lung cancer is exposure to tobacco smoke that contains .4000 components, many of which are genotoxic (1, 2) . DNA adduct formation is considered to be one of the key steps in tobacco carcinogenesis (3) . Various types of DNA adducts have been identified in the lungs of smokers to include: smoking-related bulky [polycyclic aromatic hydrocarbons (PAH)-derived] DNA adducts, that are formed by complex mixtures of PAH present in tobacco smoke (3) (4) (5) ; O-and N-alkylated DNA bases mainly formed from tobaccospecific nitrosamines (6-9) and other DNA adducts, e.g. generated by 4-aminobiphenyl (10) and malondialdehyde (11) . In the urine of smokers, N3-methyladenine (12-15), N3-ethyladenine (12) and 1,N 6 -ethenoadenine and 3,N 4 -ethenocytosine adducts (16) derived from lipid peroxidation products were found.
Godschalk et al. (17) using an ultrasensitive immunoenriched 32 P-postlabelling-high-performance liquid chromatography (HPLC) method in a pilot study detected significantly elevated levels of O 4 -ethylthymidine (O 4 -etT) in the lungs of 13 smokers as compared to 11 non-smokers (18) . O 4 -etT (for structure, see Figure 1 ) is a potentially promutagenic DNA lesion (19, 20) . Although cigarette smoke contains low amounts (not detected to 25 ng/cigarette) of diethylnitrosamine (DEN) (2), the identity and source of the ethylating agent(s) in cigarette smoke have not been firmly established (8, 18) . O 4 -etT is initially formed in DNA after exposure to ethylating agents at relatively low levels (21-24), but as it seems to be slowly removed from DNA (25) it may accumulate to biologically relevant levels of genotoxic lesions.
Within the framework of a multi-endpoint molecular epidemiological study, we have previously investigated smoking exposure-related biomarkers in Hungarian lung cancer patients (26, 27) . Herein we extended these investigations and analysed the formation of O 4 -etT in lung DNA. Our aims were (i) to confirm in a larger and geographically different study population the smoking-related formation of O 4 -etT in human lung; (ii) to explore the persistence in DNA and dose dependency of O 4 -etT and (iii) to assess if a correlation exists between levels of O 4 -etT and bulky DNA adducts.
Materials and methods

Study subjects
Archived DNA samples originated from histologically normal peripheral lung tissue samples from 64 Hungarian lung cancer patients who underwent lung resection for lung cancer in the Korányi National Institute of Pulmonology, Budapest, between 2000 and 2004. The present study population (Table I) was part of a larger study population investigated previously (27) . The samples were obtained with informed consent of the patients and the research was approved by the local and national ethics committee in Hungary. The selection of samples was based on the availability of sufficient amount of DNA (.50 lg). As in our earlier studies on bulky DNA adducts (26, 28) , four smoking categories were defined as follows: current smokers (CS) who smoked until the surgery, shortterm ex-smokers (SES) who gave up smoking 1 year before the surgery, longterm ex-smokers (LES) who gave up smoking .1 year before the surgery and never-smokers (NS).
Sample collection, DNA isolation and storage Sample collection and DNA isolation by using the phenol-chloroform-isoamyl alcohol extraction procedure was described previously (26, 29) . DNA was stored for 2-6 years in 1.5-mM sodium chloride and 0.15-mM sodium citrate solution, pH 7.0 (1/100 saline sodium citrate solution) at -100°C and evaporated to dryness before shipment at ambient temperature to DKFZ, Heidelberg. There the dry DNA samples were stored at -80°C until use. Bulky DNA adduct measurement Bulky DNA adduct levels were determined by 32 P-postlabelling with nuclease P1 adduct enrichment as described earlier (26) .
Statistical analyses
The statistical analyses were performed with GraphPad Prism 4.0 software, by using Mann-Whitney U test and Spearman correlation test. A two-tailed P-value ,0.05 was considered as statistically significant.
Results
Relationship between O 4 -etT adduct level and smoking status
In all lung tissues analysed (n 5 64), O 4 -etT levels (expressed per 10 8 thymidines) ranged from 0.01 to 3.91 according to smoking categories that are shown in Figure 2A . The difference, either between CS and SES or between LES and NS was not statistically significant. The combined group of CS and SES had 1.7-fold higher adduct level than the combined group of LES and NS (mean AE SD, 0.78 AE 0.76 versus 0.45 AE 0.44 O 4 -etT/10 8 thymidines, P 5 0.015). O 4 -etT levels were investigated among CS with respect to smoking dose ( Figure 3) . O 4 -etT levels in CS as a function of daily cigarette dose ( Figure 3A ) and cumulative dose ( Figure 3B ) were compared to the adduct level in NS. There was no apparent dose-response relationship between O 4 -etT levels and the daily or cumulative smoking dose. The interindividual differences (highest versus lowest) in the adduct levels at a given smoking dose varied over a large range, e.g. at 20 cigarettes/day, the difference was 14-fold and 6-fold at 30 pack-years. 
Comparison of O 4 -etT and bulky DNA adduct levels by smoking status
Results of the bulky DNA adduct determinations were taken from our previous studies (26, 27) . Figure 2B shows the bulky DNA adduct levels of the sample set according to smoking categories. As seen for O 4 -etT, bulky DNA adducts were statistically significantly higher in the combined group of CS and SES than in the combined LES and NS group (P , 0.0001).
There was no statistically significant correlation between O 4 -etT and bulky DNA adduct levels in the whole study population (Spearman correlation coefficient r 5 0.16, P 5 0.19, n 5 64), and in any of the four smoking categories (data not shown). Figure 4B shows the persistence of bulky DNA adducts reflecting in part their removal by DNA repair processes. All of the LES were within the 2.0-fold mean value of the bulky DNA adduct level seen in NS. In contrast to O 4 -etT, there was no essential difference between the mean bulky DNA adduct level of LES and NS (5.5 versus 5.3 bulky DNA adducts/10 8 nucleotides, respectively).
Discussion
Various types of DNA adducts have been associated with smoking; however, there exist only limited data on the formation and relevance of O 4 -etT in human tissues with regard to their role in mutagenesis and carcinogenesis (17, 18) . The present study provided some novel results on the dosimetry of O 4 -etT formation and smoking habits. Our results confirm that O 4 -etT is formed in human lung due to cigarette smoking, which is in keeping with the pilot study that first reported an increase of O 4 -etT in smoker's lung (18) . An $2.4-fold higher O 4 -etT level was found in cigarette smokers compared to non-smokers as measured in nontumourous lung tissue. We conclude from the above and our study that voluntary cigarette smoking is the main, but not the only source of O 4 -etT formation. It was also detected in the lung of NS, which could be derived from passive smoke exposure; DEN levels were up to 40 times higher in side-stream cigarette smoke than in main-stream cigarette smoke (30) . However, the true origin of this background level is not known.
In experimental studies, O 4 -etT is formed from alkylating agents at a low yield as compared to other alkylated DNA (22) . In a study of lung cancer patients, N7-methylguanine level was detected in the order of 170 adducts/10 8 nucleotides in smokers' lung (6), whereas in our present study O 4 -etT levels ranged ,1 adduct/10 8 thymidines. There was no apparent dose-dependent association between the smoking dose and the O 4 -etT levels among smokers. Possibly, the number of subjects at different smoke exposure levels was too small, and especially the low smoking doses were underrepresented. The presence of a plateau in DNA adduct formation in humans has been shown for bulky DNA adducts (28) and experimentally also for alkylating agents: The concentration of O 4 -methyldeoxythymidine in rat lung reached a steady-state level after 4 days of treatment with the tobacco-specific nitrosamine, 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone (31) .
Our results further suggest that O 4 -etT appears persistent in human lung for several years after quitting smoking: O 4 -etT levels in one-third of the LES were above the 2.0-fold mean O 4 -etT level seen in NS. Thus, O 4 -etT persists much longer in human lung than do bulky DNA adducts, for which an apparent half-life of 1.7 years was estimated earlier (28) . In this study, the precise O 4 -etT half-life could not be assessed because of the large inter-individual variations. To date, no data on the elimination time of O 4 -alkylthymidine from human lung have been reported. In an experimental study, the half-life of O 4 -etT in liver was on average 19 days ranging from16 to 24 days following treatment of rats with DEN (22) . In N-ethyl-Nnitrosourea-treated human foetal kidney epithelial and skin fibroblast cells, $50% of the initial damage of O 4 -etdT was repaired during 72 h (32) .
The complex repair process of different alkylation products, including O -alkylthymidine (33, 34) , whereas others did not (23, 35) . In human cell lines, mutant alkylguanine transferase facilitated efficient recognition and repair of O 4 -alkylthymines (36) . MGMT promoter methylation was associated with TP53 tumour suppressor gene mutation in human lung tumours (37, 38) .
In our study, both O 4 -etT and bulky DNA adduct levels reflected the difference of exposure between smokers and nonsmokers. Unexpectedly, we found no statistically significant correlation between O 4 -etT and bulky DNA adduct levels either in the whole study population or in the smoking subcategories. This differs from the finding of the earlier pilot study that reported positive correlations (r 5 0.6, P , 0.01) between O 4 -etT versus bulky DNA (and also versus putative benzo[a]pyrene-7,8-diol 9,10-epoxide-DNA) adduct levels (18) . The difference might stem from the brands of cigarettes and, even more, from the background levels of environmentally and endogenously induced adducts in different study populations, that affect the relative difference or the ratio of the mean adduct levels between smokers and non-smokers. Our finding regarding the lack of correlation between individual levels of chemically different DNA adduct structures is not unique. Scarce and controversial results have been found in the literature on the correlation between bulky/PAH-DNA adducts and chemically specific single DNA adduct structures (39) . The correlation should be influenced by the coexistence of closely linked but independent pathways among the metabolic activation processes of the different xenobiotic structures within a complex mixture and of differences in the kinetics of DNA adduct formation and elimination. Nevertheless, our findings in a larger cohort support that the major source of both adduct types is exposure to cigarette smoke, but their metabolic pathways, the rates of DNA adduct formation and repair processes differ.
In conclusion, we have confirmed that the level of the putative promutagenic O 4 -etT in human lung DNA is increased by smoking. This study also provided for the first time information on the long persistence of O 4 -etT in human lung, which together with its potential miscoding activity may implicate this lesion in tobacco carcinogenesis. Our data did not reveal a significantly positive relationship between O 4 -etT and bulky DNA adduct formation in smoker's lung. Validation studies of O 4 -etT as a potential biomarker of smoking-related genotoxic exposure in humans are now warranted, using the available sensitive and specific detection method. 
